Abstract
Motor neuron disease, in the vast majority of cases occurring in the form of amyotrophic lateral sclerosis is a rare neurodegenerative disease with a prevalence of 2–3 cases per 100 thousand people in the population. The paper presents the results of a clinical observation of a patient with probable amyotrophic lateral sclerosis which occurs comorbidly with autoimmune myositis since the diagnosis was made in January 2023, as well as the effect of a comprehensive 21-day rehabilitation on clinical characteristics in the rehabilitation department of PARUS medical resort & SPA, LLC, near Novosibirsk. The individual rehabilitation course included physical rehabilitation, restorative training, apparatus physiotherapy and occupational therapy in addition to medication. By the end of the rehabilitation course, the indicators of the measured clinical scales improved: ALSFRS-R – by 3 times, MRC muscle strength – 2 times, Barthel – 2 times, Beck – 1.5 times, according to the walking scale of the Institute of Neurology – 1.3 times, paresis scale of the Institute of Neurology – 2 times, dysphagia – 4.5 times. The study allows expanding and supplementing the available data regarding the difficulty of verifying the diagnosis which directly affects the complexity of assessing the rehabilitation prognosis, setting rehabilitation goals and objectives in a patient with difficult to differentiate comorbid pathology.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
